ArticleAnnals of surgical oncology2023

Overall Survival Following Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy in Clinically Node Negative T1 Triple Negative Breast Cancer.

Kai Huang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.